CCHR Warns Troubled Teen Camps Must Be Banned as Deaths Spur Closures
LOS ANGELES, Calif., July 7, 2025 (SEND2PRESS NEWSWIRE) — Despite dozens of closures of abusive 'troubled teen' programs in behavioral and psychiatric centers, including wilderness camps in recent years, a leading mental health industry watchdog warns that children's lives remain at risk unless stronger laws ban the worst offenders and the secretive youth transport practices that feed them. The Citizens Commission on Human Rights International (CCHR), a nonprofit mental health industry watchdog, says that while public outrage and media exposure have forced some notorious facilities to close, the underlying problems that enable these abusive programs still persist—and more children will die if lawmakers do not act. Two teen suicides occurred last month in a North Carolina behavioral facility, forcing its closure.[1]
'These so-called 'therapy' camps have a disturbing history of traumatizing vulnerable young people while charging desperate families tens of thousands of dollars,' said Jan Eastgate, international president of CCHR. 'When a child dies in these programs, that should be the last death. We need permanent bans—not just temporary closures.'
Wilderness therapy camps, residential treatment centers, and other 'troubled teen' programs often market themselves as life-saving alternatives for youth struggling with behavioral or emotional challenges. But critics say that behind the glossy brochures is an industry built on secrecy, harsh discipline, and abusive staff.
'Many of the methods used in these camps would violate the Geneva Convention if applied to prisoners of war,' wrote journalist Maia Szalavitz in Help at Any Cost: How the Troubled Teen Industry Cons Parents and Hurts Kids.[2] Her book, along with years of survivor accounts and investigations, has shown how children are subjected to extreme isolation, physical restraints, humiliation, and medical neglect.
Other recent closures have been prompted by tragic deaths, including a 12-year-old boy who died within 24 hours of admission to a wilderness program in North Carolina after being restrained.
Numerous youth facilities and wilderness camps across the U.S. have faced criminal charges, lawsuits, and license revocations following deaths, suicides, or widespread abuse. Many charged fees ranging from $30,000 to more than $100,000 per child per year.[3]
State audits have exposed repeated failures. A 2022 Salt Lake Tribune investigation in Utah—long known as a hub for these programs—found thousands of inspection reports detailing rampant abuse, sedation, and neglect even after an oversight law was passed in 2021.[4]
Utah Senator Mike McKell, who spearheaded the law admitted the state had been 'learning the hard way,' that this was inadequate, citing at least seven preventable deaths since 2021. He led the amendment to the law this year, creating a children's ombudsman and new whistleblower protections.[5]
In Maryland, legislators led by Delegate Vaughn Stewart passed the Preventing Abduction in Youth Transport Act this year to curb some of the worst practices, including the forcible removal of children from their homes at night by 'secure youth transport' companies. The law prohibits dangerous restraint use by these companies. This often-unregulated youth transport industry has been described by journalists as 'authorized kidnapping,' with children handcuffed or restrained as they are shuttled to remote facilities far from home. Survivors, including prominent advocates, Paris Hilton, attorneys and CCHR, say this practice can leave children deeply traumatized before they even reach a program.[6]
CCHR points to a deeper issue fueling the troubled teen industry's survival: the widespread psychiatrizing of normal childhood and adolescent behavior.
'Too many of these kids are labeled with vague or unscientific mental health diagnoses simply for acting like teenagers,' said Eastgate. 'This creates a pipeline to often harmful treatments—and big profits.'
Psychiatrist Allen Frances, who chaired the task force that revised the fourth edition of the ' Diagnostic and Statistical Manual of Mental Disorders' (DSM), famously admitted that the expansion of psychiatric labels has been excessive. ADHD diagnoses alone have tripled over the past two decades.
'Human nature just doesn't change that quickly,' Frances said. 'Our kids haven't suddenly become sicker; it's just that diagnoses are applied to them more loosely.'
This diagnostic inflation has proven lucrative. In the U.S., the troubled teen segment alone is estimated to be worth $50 billion.[7] Between 2017 and 2021, total medical spending for pediatric mental health conditions jumped by over 45%, with these conditions now making up nearly half of all pediatric medical spending—around $31 billion in direct child costs and $59 billion in related household expenses.[8]
CCHR says that while some private equity firms are quietly exiting the troubled teen market amid mounting lawsuits and bad press, the industry continues to operate largely in the shadows—propped up by misleading advertising, false diagnoses, and an unregulated transport network.
'Every state must investigate these programs thoroughly, shut down any that endanger children's lives, and permanently ban the worst practices,' said Eastgate.
The watchdog says that true reform must hold facilities accountable for abuse and deaths, end the use of psychiatric labels to funnel youth into profit-driven programs, and shut down the loopholes that allow dangerous operators to rebrand and reopen under new names.
'The recent closures show that change is possible when families, survivors, the media, and lawmakers work together,' said Eastgate. 'But as long as one child can still be abused or die in these behavioral-psychiatric camps, this fight isn't over. No child's life should ever be gambled away for profit.'
CCHR is a nonprofit mental health watchdog established in 1969 by the Church of Scientology and Professor of Psychiatry, Dr. Thomas Szasz. It has helped enact more than 190 reforms worldwide to protect individuals from abusive or coercive psychiatric practices.
To learn more, visit: https://www.cchrint.org/2025/07/03/deaths-spur-closures-but-troubled-teen-camps-must-be-banned/
Sources:
[1] https://avlwatchdog.org/asheville-academy-trails-carolina-owner-faced-financial-upheaval-before-deaths/
[2] https://www.mirror.co.uk/news/us-news/inside-americas-disturbing-wilderness-therapy-32203146
[3] https://journals.sagepub.com/doi/full/10.1177/2043610619900514
[4] https://www.kuer.org/politics-government/2021-03-03/new-regulations-for-the-states-troubled-teen-industry-win-final-legislative-approval
[5] https://ksltv.com/politics-elections/lawmakers-push-for-tougher-oversight-after-several-deaths-in-utah-teen-treatment-centers-2/743747/
[6] https://www.cchrint.org/2025/02/14/maryland-bill-targets-psychiatric-transport-abuses/; https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0497?ys=2025RS;
[7] https://www.dw.com/en/troubled-teen-industry-in-the-usa-the-prison-school-scandal/a-69963580
[8] https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2815870
MULTIMEDIA:
Image link for media: https://www.Send2Press.com/300dpi/25-0707-s2p-cchract-300dpi.jpg
Image caption: CCHR says while public outrage and media exposure have forced some notorious facilities to close, the underlying problems that enable these abusive programs still persist – and more children will die if lawmakers do not act.
NEWS SOURCE: Citizens Commission on Human Rights
Keywords: General Editorial, Citizens Commission on Human Rights, CCHR International, Troubled Teen Industry, Wilderness Camps, Jan Eastgate, LOS ANGELES, Calif.
This press release was issued on behalf of the news source (Citizens Commission on Human Rights) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P127454 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/cchr-warns-troubled-teen-camps-must-be-banned-as-deaths-spur-closures/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
OCD's Origins Might Not Lie in The Brain Like We Thought
Obsessive-compulsive disorder (OCD) affects up to 3 percent of people worldwide and remains one of the most challenging mental health conditions to treat effectively. That makes any fresh insight into OCD's root causes especially valuable – like a new study pointing to a surprising suspect: the bacteria living in our gut. The research from China explored how the gut microbiota – the complex community of bacteria that live in the digestive system – may influence whether a person develops OCD, and identified six types of bacteria that appear to be linked with the condition. A steady stream of studies has shown close connections between the brain and the gut, but this is the first to provide compelling evidence that gut bacteria may actually help cause it. The researchers used genetic data to strengthen the case for causation. Related: "Previous studies have indicated a potential link between the gut microbiota and OCD," write the researchers from Chongqing Medical University in their published paper. "However, the exact causal relationship remains uncertain." "Our analysis suggested that specific gut microbiota might have a causal relationship with OCD, revealing potential intervention strategies for the prevention and treatment of this disorder." To explore this link, the researchers used a genetic approach known as Mendelian randomization, which allows scientists to infer causality by analyzing genetic variants that influence both OCD and gut bacteria. They assessed links between genetic data and gut bacteria in a sample of 18,340 people, and the links between genetic data and OCD in a separate sample of 199,169 people. Although these were two discrete sets of data, the study used Mendelian randomization to essentially bridge the gap and connect gut bacteria patterns with OCD. Because our genes are fixed at birth and not shaped by environment or lifestyle, this method helps strengthen the case that gut bacteria might directly contribute to OCD, rather than just being an effect of it. However, more data and more controlled experiments will be needed to confirm a causal link. Three types of bacteria appeared to be protective against OCD: Proteobacteria, Ruminococcaceae, and Bilophila. Another three seemed to increase the risk of OCD: Bacillales, Eubacterium, and Lachnospiraceae UCG001. Interestingly, many of these bacteria have been linked with the brain before. For example, previous studies have found a connection between low levels of Ruminococcaceae species and depression. These findings expand what we already know about the gut-brain axis and how one can affect the other. "Future research should employ longitudinal designs and diverse populations to validate and expand upon these findings, as well as a more in-depth classification of microbes and their metabolic products, to further understand the role of gut microbiota in OCD," write the researchers. Down the line – and it's still a way off – we may have a new way to treat or prevent OCD, by controlling gut bacteria mixtures. For people living with the condition – and the families, friends, and clinicians who support them – this could eventually offer new hope. "Despite the utilization of cognitive behavioral therapy and selective serotonin reuptake inhibitors in OCD treatment, a notable 25–40 percent of patients experience suboptimal or no response to these interventions," write the researchers. "Moreover, the personal and societal toll of OCD is substantial." The research has been published in the Journal of Affective Disorders. The News Cycle Is a Stress Monster. But There's a Healthy Way to Stay Informed. Surprise Discovery About Sugar in The Brain Could Help Fight Alzheimer's Air Pollution 'Strongly Associated' With DNA Mutations Tied to Lung Cancer
Yahoo
35 minutes ago
- Yahoo
Palm Beach physician pioneering new advances in ALS and inflammatory disease treatment
A Palm Beach physician-scientist is leading efforts to create breakthrough treatments for Parkinson's, ALS, Alzheimer's and other diseases through a biotech company she established nearly a decade ago. Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of "T regulatory cell" therapies for the treatment of autoimmune diseases and inflammatory disorders. T regulatory cells, or Tregs (pronounced tee-regs), are natural immune system regulator cells that suppress the activity of other immune cells to prevent excessive inflammation and autoimmune reactions. Before launching Cellenkos, Parmar conducted extensive research on these cells and developed therapies based on them. While working as an oncologist/hematologist in the Department of Stem Cell Transplantation and Cellular Therapy at the University of Texas's MD Anderson Cancer in Houston in 2009, she developed treatments using T regulatory cells derived from umbilical cord blood to help prevent graft-versus-host disease (GVHD), a complication that can occur after an allogeneic stem cell or bone marrow transplant. Parmar told the Daily News it was 'very discouraging' to watch patients die from GVHD, which motivated her to focus her research on controlling the inflammation caused by donor cells, starting with the discovery of T regulatory cells. As she continued to conduct her research, she discovered that these cells had uses beyond preventing GVHD. "We found that the application of these cells is beyond just that one niche," she told the Daily News. "It can be applied to any autoimmune disease, to any inflammatory disorder." In 2016, the cell technology Parmar developed at MD Anderson was licensed to Cellenkos, which now supports her ongoing research through a sponsored research agreement. Since then, Parmar has focused on her work advancing targeted Treg cell therapies designed to ease inflammation and regulate immune function. Cellenkos is currently in clinical trials for various inflammatory and autoimmune diseases, including ALS, bone marrow failure, severe COVID-19 and myelofibrosis. Results have been positive so far, Parmar said, noting that ALS patients have seen a delay in disease progression and functional decline and an improvement in quality of life. "We have made some great strides in neurodegenerative disease," she said. "We just published a paper in the New England Journal of Medicine Evidence on ALS, where we showed not only disease halting, but slight improvement in resolving inflammation. That research has applications beyond just ALS. We are hoping as we are garnering more funding, we can go after Parkinson's, Alzheimer's and multiple sclerosis." Inflammation is the root cause of many diseases including cardiac, respiratory, neurological and hematological disorders, Parmar said, and it also drives many autoimmune diseases. Parmar's cell therapies restore immune balance by targeting harmful T cells — a type of white blood cell called lymphocytes — that can mistakenly attack healthy cells in the body, and retraining the body's own defense mechanisms. "We have a drug that heals inside out," she said. "We believe that we neutralize the bad player, which may not have initiated the inflammation, but definitely plays a key role in the propagation of widespread inflammation." Parmar, a mother of three who lives in Palm Beach's North End and travels regularly to Houston, where Cellenkos is based, said she remains committed to developing cell therapies targeting a broad range of autoimmune and inflammatory diseases. Cellenkos is pursuing funding for larger ALS research studies in the U.S., and it is also preparing for the next phase of clinical trials required for federal Food and Drug Administration approval. Parmar said she sees Palm Beach County's emergence as a neuroscience hub as a key benefit of her move, and she hopes it will lead to new research, development, and partnership opportunities. "We're incredibly excited about the momentum building in the Palm Beach and Jupiter area around neuroscience innovation," she said. "With new opportunities for R&D collaboration in the region, it presents an ideal environment for us to expand. We see great potential not only to develop a manufacturing facility for neurological compounds … but also to establish a dedicated treatment center that brings these breakthroughs directly to patients.' Jodie Wagner is a journalist at the Palm Beach Daily News, part of the USA TODAY Florida Network. You can reach her at jwagner@ This article originally appeared on Palm Beach Daily News: Palm Beach physician-scientist pioneering groundbreaking ALS therapy
Yahoo
35 minutes ago
- Yahoo
Whoa—Scientists Found a Part of Human Cells We Never Knew Existed
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Here's what you'll learn when you read this story: Hemifusomes are fused vesicles, or sacs of fluid, that were previously unknown to exist inside cells. They were discovered using cryo-electron tomography, which literally freezes them in time, and confirmed to be actual organelles and not just background noise. Because hemifusomes collect and recycle junk proteins, they could mean more effective treatments for diseases caused and aggravated by protein plaque buildup, such as Alzheimer's. Back in high school biology, most of us learned about the innards of a cell, or its organelles, from ribosomes to mitochondria to the endoplasmic reticulum, and probably had to identify them on our midterms. Now, an unexpected discovery will probably soon rewrite those textbooks. The hemifusome is the new organelle that high school students (much to their chagrin) will have to remember. Biophysicist Seham Ebrahim of the University of Virginia and her team of researchers were observing mammalian cells when they discovered hemifusomes, which previously eluded detection because they are even smaller than mitochondria and can easily blur or be mistaken for background noise. These nano-orbs, which look like they have, noses bear an uncanny resemblance to BB-8 or the profiles of certain Muppets. Pop culture references aside, their function of organizing, cleaning up, and recycling proteins could potentially unlock new treatments for genetic and neurodegenerative diseases. Hemifusomes consist of two vesicles, which are membrane sacs filled with liquid and formed by hemifusion, meaning that the smaller of the two is fused to the larger one like a hemisphere, almost as if its other half is missing. This occurs when the outer layers of two membranes merge first while the inner membrane layers stay open until a thin connection between them forms a new vesicle. The attached vesicles are sometimes found on the outside of the organelle and sometimes on the inside, and though where exactly these vesicles originate is still unknown, hemifusomes are thought to facilitate the formation of new vesicles that transport materials throughout the cell. This is probably how they take out cellular trash. Ebrahim used cryo-electron tomography, or cryo-ET, to observe and image hemifusomes. The cells, which were kept at cryogenic temperatures, were imaged in two dimensions using an electron microscope. Superfast cameras then took multiple photos of the frozen cells and their organelles. From these photos, single images were created using algorithms, upgrading the 2D images to 3D. 'Our observation of hemifusomes in four different cell lines originating from various species and tissues and frozen as close as possible to their native state suggests that they may be common components of the cell periphery in a wide range of cells and tissues,' she said in a study recently published in Nature Communications. Something else the researchers wanted to explore was what kind of relationship hemifusomes had with endosomes, which are vesicles that transport extracellular material into the cell via the process of endocytosis. The cell's plasma membrane will fold inward to surround matter, such as food molecules, in the surrounding fluid. These molecules are then taken in by the cell, whose plasma membrane pinches off to create an endosome that carries them into the cytoplasm. Endosomes can also form through the fusion of vesicles that already exist within the cell. Ebrahim traced the activity of endosomes and hemifusomes, but they did not appear to work together. What makes hemifusomes so important is how they collect and recycle junk proteins. Many studies have shown that the buildup of protein plaque in the brain can cause and aggravate neurodegenerative diseases such as dementia and Alzheimer's, and more understanding about how these organelles operate could lead to the development of treatments that work with them. 'Future research should focus on determining whether hemifusomes and compound hemifusomes are present in other cellular regions,' Ebrahim said, 'and on elucidating the molecular mechanisms underlying their formation, stability, and function, as well as their broader implications for cellular physiology and pathology.' You Might Also Like The Do's and Don'ts of Using Painter's Tape The Best Portable BBQ Grills for Cooking Anywhere Can a Smart Watch Prolong Your Life?
